1. Home
  2. Global Directory
  3. Thomas Forschbach

Thomas Forschbach

Partner
London | Paris
  • 99 Bishopsgate
  • London EC2M 3XF
  • United Kingdom
Profile Experience

Thomas Forschbach is a partner in Latham & Watkins' London and Paris offices. He has advised international clients on mergers and acquisitions and private equity for over 25 years and is one of Europe’s most experienced and renowned lawyers in his field.

Triple-qualified in French, English, and German law, Mr. Forschbach is active on both French and cross-border leveraged buyout (LBO) transactions across a broad spectrum of industry sectors.

Recognition

Named to the Hall of Fame in The Legal 500 EMEA 2022

Mr. Forschbach is recognized as a Leading Individual. Chambers Europe 2022

Recognized as a Leading Individual. The Legal 500 EMEA 2020

Clients enthuse: "Mr. Forschbach is very commercial, pragmatic yet technical and with a huge amount of experience." Chambers Europe 2020

Nominated in the Hall of Fame and recognized as a Leading Individual. The Legal 500 EMEA 2019

Clients describe Mr. Forschbach as “Excellent.” Chambers Europe 2019

Recognized for his work in Private Equity: Transactions by The Legal 500 2018

Lawyer of the Year Best Lawyers 2018

“A leader” in the French private equity market. Qualified in France, Germany and the UK, he boasts extensive experience advising institutional investors and private equity clients on high-profile transactions. Chambers Europe 2018

Mr. Forschbach’s representative matters over the last two years include advising:

  • Astorg on its binding agreement to acquire CordenPharma, a leading pharmaceutical contract development and manufacturing organization, from International Chemical Investors Group (ICIG), a privately owned industrial group
  • Worldline, the European leader in payments services, on the proposed binding offer by Apollo funds to acquire its Terminals, Solutions & Services business (TSS)
  • Astorg in the acquisition of IQ-EQ by a Continuation Fund
  • Astorg and Goldman Sachs in the sale of HRA Pharma, a rapidly expanding innovation-driven consumer healthcare company, to Perrigo
  • Astorg in its acquisition of Solina, the leading European manufacturer of ingredient and seasoning blends for the food industry from Ardian
  • Elsan Group, a portfolio company of KKR, in its acquisition of  Groupe C2S, a France-based company operating private clinics
  • KKR and the founders of Webhelp in the €2.4 billion sale of the company to GBL (International)
  • Astorg in the sale and reinvestment in Audiotonix, premier audio mixing consoles provider
  • Astorg in its acquisition of eResearchTechnology, Inc. (ERT), a leading global data and technology company
  • Eurazeo Capital in its acquisition of Dutch Ophthalmic Research Center (DORC), a medical technology company from Montagu
  • Astorg Partners in the acquisition of Anaqua Inc., an IP administration business from Insight Venture Partners
  • BC Partners in its sale of the Antelliq Group, a France-based developer of digital animal identification, traceability, and monitoring solutions to Merck for €3.25 billion
  • Intermediate Capital Group in its sale of the Stella Group, a France-based manufacturer of custom-made curtains, roller shutters, gates, and sectional doors, to PAI Partners
  • Astorg in its acquisition of Nemera, a leading global manufacturer of drug administration systems for the pharmaceutical industry from Montagu
  • Ardian in its sale of Groupe SIACI SAINT HONORE to Charterhouse
  • Caisse de Depot et Placement du Quebec (CDPQ) in its acquisition of a minority, and stake in Sebia, a France-based company that researches, develops, and manufactures analytical and diagnostic systems

Qualifications and Education

Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.